← Back to Search

Supportive care interventions for Multiple Myeloma

N/A

Waitlist Available

Led By Christopher E Jensen, MD

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months from enrollment

Awards & highlights

Study Summary

This trial will help determine whether a systematic geriatric assessment can improve the care of older myeloma patients by identifying and addressing problems that could impact their cancer outcomes.

Eligible Conditions

Multiple Myeloma
Physical Disabilities
Multiple Disabilities

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months from enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months from enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months from enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention attendance (feasibility)

Secondary outcome measures

Subject satisfaction with program (acceptability)

Other outcome measures

European Organization for Research and Treatment of Cancer (EORTC) Physical Function scores

Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation score

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive CareExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor

351 Previous Clinical Trials

88,316 Total Patients Enrolled

17 Trials studying Multiple Myeloma

21,996 Patients Enrolled for Multiple Myeloma

Conquer Cancer FoundationOTHER

19 Previous Clinical Trials

3,959 Total Patients Enrolled

1 Trials studying Multiple Myeloma

90 Patients Enrolled for Multiple Myeloma

Christopher E Jensen, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment size of this clinical investigation?

"Affirmative. Data hosted on clinicaltrials.gov proves that the trial, which was originally posted on November 15th 2021 is actively enrolling patients. There are 40 positions available at a single medical facility."

Answered by AI

Are there still opportunities available for individuals to join this trial?

"As per clinicaltrials.gov, this trial is actively looking for participants to join. It was initially posted on November 15th 2021 and the most recent update took place September 6th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

2021. "Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04999085.